Paige

With a potential 60 percent increase in the number of cancer cases globally in the next two decades and a decrease in the number of pathologists relative to this diagnostic demand, the need to expedite advancements in pathology is pressing. This issue is further exacerbated by the fact that pathology — despite being the foundation of diagnosis — has yet to become digital. Led by a team of experts in pathology, machine learning, healthcare, and business, Paige strives to make it possible to not only provide additional information from digital slides to help pathologists perform their diagnostic work efficiently and accurately, but also to go beyond this traditional work to extract new diagnostic information from pathology slides and patient samples that have the potential to support informed treatment pathways for patients. Paige technology is also helping life sciences companies evaluate and design personalized treatments for patients.